表紙
市場調査レポート

感染症の核酸検査市場の見通し

Future Infectious Disease Nucleic Acid Testing

発行 Venture Planning Group 商品コード 231461
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。

Local License: 同一事業所内

Back to Top
感染症の核酸検査市場の見通し Future Infectious Disease Nucleic Acid Testing
出版日: ページ情報: 英文
概要

当レポートでは、主な感染症の臨床的な意義や市場ニーズの概要とともに、分子診断技術と製品の開発/マーケティング企業のリストを提供して、概略以下の構成でお届けいたします。

第1章 概要

第2章 主な感染症

  • AIDS
  • アデノウイルス
  • 炭疽菌
  • バベシア症
  • BEAおよびその他のバルトネラ感染症
  • シャーガス病
  • カンピロバクター
  • クラミジア
  • クロイツフェルト・ヤコブ病
  • サイトメガロ・ウイルス
  • エボラウイルス
  • エコー・ウイルス
  • 脳炎
  • エンテロウイルス
  • エプスタイン・バーウイルス
  • 淋病
  • 肝炎
  • 単純ヘルペスウイルス
  • レジオネラ
  • ライム病
  • マラリア
  • マイコプラズマ
  • パピロマウイルス/HPV
  • パルボウイルスB19
  • 肺炎
  • ポリオーマウイルス
  • サルモネラ菌
  • 細菌性赤痢
  • 連鎖球菌
  • トキソプラズマ症
  • 結核
  • 西ナイルウイルス
  • エルシニア

第3章 抗生物質感受性

図表

目次
Product Code: VPNAT776-1

This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains: 360 pages and 20 tables.

Table of Contents

1. Overview

2. Major Infectious Diseases

AIDS

  • Structure and Composition
  • Classification
  • AIDS Origins
  • Animal Lentivirus Systems
  • Virus Receptors
  • HIV Infections in Humans
    • Pathogenesis and Pathology
  • CD4T Lymphocytes and Memory Cells
  • Monocytes and Macrophages
  • Lymphoid Organs
  • Neural Cells
  • Viral Coinfections
    • Clinical Findings
  • Plasma Viral Load
  • Pediatric AIDS
    • Neurologic Disease
    • Opportunistic Infections
    • Cancer
  • Immunity
    • Virus Isolation
    • Serology
    • Viral Nucleic Acid/Antigen Detection
  • Epidemiology
    • Worldwide Spread of AIDS
    • United States
    • Routes of Transmission
  • DNA Probes
    • Overview
    • Quantitative PCR
    • In Situ PCR
    • Needed Improvements
  • Viral Load/Drug Resistance Testing
  • Genotype and Phenotype Testing
  • Blood Banking Considerations

Adenovirus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs
  • Adeno-Associated Viruses (AAV)

Anthrax/Bacillus Anthracis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Babesiosis

  • Background

BEA and Other Bartonella Diseases

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Chagas Disease

  • Background

Campylobacter

  • Background
  • Diagnostic Tests
    • Culture Identification
  • Vaccines and Drugs

Chlamydia

  • Background
    • Chlamydia psittaci
    • Chlmaydia pneumoniae
    • Chlamydia trachomatis
  • Diagnostic Tests
  • Vaccines and Drugs

Creutzfeldt-Jakob's Disease

  • Background
  • Blood Transmission
  • Diagnostic Tests
  • Major Commercial and Academic Players
    • Bayer
    • Disease Sciences/Bio Tec Global
    • Imperial College School of Medicine
    • Ortho-Clinical Diagnostics
    • Pall
    • ProMetic Life Sciences
    • Proteome Sciences/Idexx
    • Q-One Biotech
    • Serono
    • U.S. Agricultural Research Service
  • Drugs
  • Vaccines

Cytomegalovirus

  • Background
    • Chorioretinitis
    • Gastrointestinal
    • Central Nervous System Disease
  • Diagnostic Tests
  • Vaccines and Drugs

Ebola Virus

  • Background
    • Epidemiology
    • Clinical Syndromes
  • Diagnostic Tests
  • Vaccines and Drugs

EchoVirus

  • Background
    • Acute Aseptic Meningitisis
    • Encephalitis
    • Exanthems
    • Respiratory Disease
    • Myopericarditis
    • Neonatal Infections
  • Diagnostic Tests
  • Vaccines and Drugs

Encephalitis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Enteroviruses

  • Background
  • Diagnostic Tests
    • Viral Isolation and Identification
    • Antibody Tests
  • Vaccines and Drugs

Epstein-Barr Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Gonorrhea

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Hepatitis

  • Hepatitis A
  • Hepatitis B
    • Structure and Composition
    • Replication
  • Hepatitis C
  • Hepatitis D (Delta)
  • Hepatitis E
  • Hepatitis G
  • Hepatitis Infections Pathology
  • Clinical Findings
  • Laboratory Tests
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
  • Virus-Host Immune Reactions
  • Epidemiology
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D (Delta)
  • Vaccines and Drugs

Herpes Simplex Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Legionella

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Lyme Disease

  • Background
    • Clinical Description
    • Clinical Case Definition
    • Laboratory Criteria for Diagnosis
    • Case Classification
  • Diagnostic Tests
  • Vaccines and Drugs

Malaria

Mycoplasma

  • Background
    • Ureaplasma Urealyticum & Mycoplasma
  • Hominis
  • Diagnostic Tests
  • Vaccines and Drugs

Papillomaviruses/HPV

  • Background
    • HPV in Cancer
    • Cervical Neoplasm
  • Diagnostic Tests
  • Vaccines and Drugs
    • Prevention

Parvovirus B19

  • Background
    • Microbiology
    • Epidemiology
    • Clinical Syndromes
    • Erythema Infectiosum (Slapped Cheek)
    • Adult Polyarthropathy
    • Transient Aplastic Crisis
    • Transient Pancytopenia
    • Red Cell Aplasia in Immunocompromised
    • Perinatal Infections
  • Diagnostic Test
  • Vaccines and Drugs

Pneumonia

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Polyomaviruses

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Salmonellosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Shigellosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Streptococci

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs
    • Group A Streptococci
    • Group B Streptococci

Toxoplasmosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Tuberculosis

  • Background
  • Diagnostic Tests
    • Microscopic Characteristics
    • Cultural Characteristics
    • Skin Tests
    • MDRTB
  • Vaccines and Drugs

West Nile Virus

  • Background
    • Clinical Syndromes
  • Diagnostic Tests
  • Vaccines and Drugs

Yersinia

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

3. Antibiotic Susceptibility

List of Tables

  • Table 1: Major Companies Developing or Marketing AIDS NAT and other Direct Identification Tests
  • Table 2: Major Companies Developing or Marketing Adenovirus NAT and other Direct Identification Tests
  • Table 3: Major Companies Developing or Marketing Campylobacter NAT and Other Direct Identification Tests
  • Table 4: Major Companies Developing or Marketing Chlamydia NAT and other Direct Identification Tests
  • Table 5: Major Companies Developing or Marketing CMV NAT and other Direct Identification Tests
  • Table 6: Major Companies Developing or Marketing EBV NAT and other Direct Identification Tests
  • Table 7: Major Companies Developing or Marketing Gonorrhea NAT and other Direct Identification Tests
  • Table 8: Major Companies Developing or Marketing Hepatitis NAT and other Direct Identification Tests
  • Table 9: Major Companies Developing or Marketing Herpes NAT and other Direct Identification Tests
  • Table 10: Major Companies Developing or Marketing Legionella NAT and other Direct Identification Tests
  • Table 11: Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests
  • Table 12: Major Companies Developing or Marketing Mycoplasma NAT And other Direct Identification Tests
  • Table 13: Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests
  • Table 14: Major Companies Developing or Marketing Pneumonia NAT And other Direct Identification Tests
  • Table 15: Major Companies Developing or Marketing Salmonella NAT And other Direct Identification Tests
  • Table 16: Major Companies Developing or Marketing Shigella NAT And other Direct Identification Tests
  • Table 17: Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests
  • Table 18: Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests
  • Table 19: Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests
Back to Top